Primary Site >> Pancreatic Cancer
Gene >> EML1
|
|
|
|---|---|---|
|
Ref: An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer. PMID: 19628080 |
Ref: Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation. PMID: 20212356 Ref: Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer. PMID: 20495354 |
Ref: Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer. PMID: 22723862 |